JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 3 filers reported holding JUNO THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $359,000 | -43.9% | 7,860 | -44.9% | 0.45% | +423.3% |
Q3 2017 | $640,000 | +65.4% | 14,261 | +10.1% | 0.09% | +48.3% |
Q2 2017 | $387,000 | +11.5% | 12,957 | -17.2% | 0.06% | -6.5% |
Q1 2017 | $347,000 | +30.0% | 15,654 | +10.6% | 0.06% | -22.5% |
Q4 2016 | $267,000 | +47.5% | 14,153 | +135.2% | 0.08% | -9.1% |
Q3 2016 | $181,000 | -21.6% | 6,017 | 0.0% | 0.09% | -48.5% |
Q2 2016 | $231,000 | +13.2% | 6,017 | +12.4% | 0.17% | -39.1% |
Q1 2016 | $204,000 | – | 5,353 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Crestline Management, LP | 25,948,799 | $1,055,857,000 | 100.00% |
Omega Fund Management, LLC | 1,329,512 | $54,098,000 | 30.46% |
SOUND ENERGY PARTNERS, INC. | 25,800 | $1,050,000 | 2.12% |
Graticule Asia Macro Advisors LLC | 435,205 | $17,708,000 | 2.06% |
BB BIOTECH AG | 1,305,000 | $53,100,000 | 1.68% |
Kazazian Asset Management, LLC | 13,376 | $544,000 | 0.69% |
Rock Springs Capital Management LP | 197,001 | $8,016,000 | 0.65% |
TURNER INVESTMENTS LLC | 69,680 | $2,835,000 | 0.57% |
MIZUHO SECURITIES USA LLC | 49,600 | $2,018,000 | 0.52% |
Private Capital Advisors, Inc. | 27,900 | $1,135,000 | 0.48% |